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Summary Objectives: There is limited information of the health-related quality of life 
(HRQoL) after surgical treatment of chest wall tumors. This cross-sectional study aimed to 
assess long-term HRQoL after chest wall reconstruction following oncological resection. 
Methods: Seventy-eight patients having undergone chest wall tumor resection and reconstruc- 
tion during 1997–2015 were invited to complete the 15D and QLQ-C30 HRQoL instruments. 
Results: Altogether, 55 patients (17 men and 38 women), with a mean (SD) age of 68 (14) years, 
completed the questionnaires (response rate 71%). Patients had been operated due to soft 
tissue sarcoma ( n = 16), advanced breast cancer ( n = 15), osteo- or chondrosarcoma ( n = 14), 
or other tumor ( n = 10). Median time after primary surgery was 66 (IQR 38, 141) months. The 
resection was full thickness in 29/55 cases and partial thickness in 26/55 cases. Chest wall 
reconstruction was required for 47/55 cases (85%). Reconstruction was performed using soft- 
tissue ﬂap in eight cases, skeletal stabilizations with mesh or mesh-cement-mesh (sandwich 
method) in 15 cases, and skeletal stabilizations and soft-tissue ﬂap in 24 cases. 
Patients’ mean 15D score (0.878, SD 0.111) was comparable to that of the age- and gender- 
standardized general population (0.891, SD 0.041). Limitations in breathing and usual activities 
were noted. The QLQ-C30 cancer-speciﬁc HRQoL was 72 points (maximum 100). Scores in the 
QLQ-C30 Functional scales ranged from 78 (Physical) to 91 (Social). 
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Conclusions: Long-term HRQoL in patients after chest wall reconstruction following oncological 
resection is fair and comparable to that of the general population. Limitations in breathing and 
usual activities can occur. 
© 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by El- 
sevier Ltd. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Chest wall resection and reconstruction are a surgical chal-
lenge. Large chest wall oncological tumor resection and re-
construction are indicated because of a primary, locally in-
vading, or metastatic tumor. The most common oncological
indications for chest wall resection are bone and cartilage
tumors, soft tissue sarcomas, and advanced lung and breast
cancer. 1,2 
Surgical operations include full-thickness or partial-
thickness resection and immediate reconstruction of the
chest. The method of reconstruction depends on the
anatomical site, depth, and size of the defect. Reconstruc-
tion is usually performed with chest wall stabilization, soft
tissue ﬂap coverage, or a combination of both. 3 Some pa-
tients also receive oncological adjuvant treatment. 4 
With modern operative techniques, coupled with pe-
rioperative and postoperative treatments, even extensive
chest wall operation can be safely performed with favor-
able results. Severe postoperative morbidity is uncommon,
and the oncological results are acceptable. The long-term
survival rates of the patients depend on the varying bio-
logical behaviors of the underlying malignancies; chondro-
/osteosarcoma, soft tissue sarcoma, advanced breast, or
lung cancer. 5 Furthermore, the presence of metastases, the
surgical results, adjuvant oncological treatments, patient
material, and selection all have an effect on long-term sur-
vival. 5,6 
There is limited information of the long-term, health-
related quality of life (HRQoL) after surgical treatment of
chest wall-related tumors with chest wall resection and re-
construction. Assessing HRQoL can provide important infor-
mation about the treatment outcomes of chest wall tumors.
As a patient-reported outcome, the HRQoL status can be
used to express patients’ opinions concerning their physical,
mental, emotional, and social well-being. Recently, HRQoL
research has been increasingly integrated into cancer
studies, and HRQOL has become an important end point of
care. 7 
Few previous studies assessing HRQoL in patients after
chest wall tumor resection all have some limitations. 8–12 
They are hampered by small sample size 8,9,11,12 ; fail to
compare results obtained in patients to those of a healthy
control population 8 , 10–12 ; or do not report the extent of the
surgical operations, need for reconstruction, and meth-
ods of reconstruction. 9,10 There are no studies assessing
postoperative HRQoL of patients with chest wall sarcoma.
Additionally, information of HRQoL after surgery is limited
in chest wall-related advanced breast-cancer. 13 
The aim of this study was to assess, using the 15D and
the QLQ-C30 HRQoL instruments, the long-term HRQoL in
patients after chest wall reconstruction following oncologi-
cal resection.  
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Patients 
The hospital electronic database at the Department of Plas-
tic Surgery, Helsinki, Finland, was searched for adult pa-
tients who had undergone oncological chest wall resection
and reconstruction between January 1, 1997, and Decem-
ber 31, 2015. Exclusion criteria were infected sternotomy
or other chest wall infection, simple benign tumor excision
with direct closure, congenital chest wall deformity, and
bronchopleural ﬁstula. The minimum follow-up time was
one year. Altogether, 135 patients met the inclusion crite-
ria. The demographic data for these 135 patients have been
described elsewhere in more detail. 5 
By the start of HRQol data collection in February 2016, 55
(41%) of the 135 surgical patients had died and two patients
had moved overseas. Two HRQoL questionnaires together
with a questionnaire consisting of items about sociodemo-
graphic and clinical details were mailed to the remaining 78
patients cross-sectionally. The patients were asked to sign
an informed consent if they were willing to participate in
the study and to return the questionnaires by mail in a pre-
paid envelope. If the patient failed to reply within a 3-week
period, a reminder letter, together with a new set of ques-
tionnaires, was sent; 55 patients (71%) answered the ques-
tionnaires. 
Postoperative complications of the patients were clas-
siﬁed according to the Clavien–Dindo classiﬁcation. 14 The
classiﬁcation consists of seven complication grades (I, II,
IIIa, IIIb, IVa, IVb, and V). The grades are based on the sever-
ity and the type of therapy needed to correct the complica-
tion. 
HRQoL results for the patients were compared with those
of an age- and gender-standardized sample of the general
population ( n = 1307) obtained from the Health 2011 Survey
in the hospital catchment area. 15 
Instruments 
The 15D questionnaire 
Generic HRQoL was measured using the 15D, 16 a comprehen-
sive instrument that covers 15 dimensions: mobility, vision,
hearing, breathing, sleeping, eating, speech, excretion,
usual activities, mental function, discomfort/symptoms,
depression, distress, vitality, and sexual activity. Respon-
dents rate each dimension on a scale from one (no prob-
lems) to ﬁve (severe problems). 
The 15D produces both an HRQoL proﬁle, based on
dimension level values, and a single index score, which
represents the overall HRQoL. Both are generated by
incorporating population-based preference weights into., Health-related quality of life after oncological resection and 
esthetic Surgery, https://doi.org/10.1016/j.bjps.2019.05.040 
Health-related quality of life 3 
ARTICLE IN PRESS 
JID: PRAS [m6+; June 10, 2019;10:10 ] 
t
i  
f  
o
E
c
0
t
i
E
T
o
i
u  
T
i
h
t  
1
l
s
S
n
e
M
z
9
S
I
w
f
S
T
a
w
a
w
p
t
w
w
(
b
w
u  
n
w
a
u
E
T
C
Table 1 Patients’ sociodemographic and clinical charac- 
teristics ( n = 55). 
Mean age, years, (SD) 68.3 (14.4) 
Female, n (%) 38 (69%) 
Male, n (%) 17 (31%) 
Body Mass Index, kg/m 2 , (SD) 26.0 (4.2) 
Median time after primary surgery, 
months (range, SD) 
66 (16–241, 67) 
Smokers 
Yes, n (%) 6 (11%) 
No, n (%) 49 (89%) 
Comorbidities 
Hypertension, n (%) 24 (44%) 
Diabetes, n (%) 10 (18%) 
Coronary heart disease, n (%) 5 (9%) 
Asthma, n (%) 5 (9%) 
Thyroid disease, n (%) 5 (9%) 
Other, n (%) 6 (11%) 
Family circumstances 
Married/cohabitation, n (%) 29 (53%) 
Widow, n (%) 10 (18%) 
Divorced, n (%) 7 (13%) 
Single, n (%) 5 (9%) 
Occupational status 
Retired, n (%) 41 (75%) 
Employment status, n (%) 13 (24%) 
Unknown, n (%) 1 (1%) 
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the dimensions. The dimension-level values and the single 
ndex score are on a zero to one scale, where zero stands
or being dead and one for best possible HRQoL (15D score)
r no problems on the dimension (dimension-level value). 
stimates place the test-retest reliability and minimal 
linically important difference of the 15D score at 0.90 and 
.015, respectively. 17,18 The 15D is comparable favorably 
o other similar, generic HRQoL instruments in their most 
mportant psychometric properties. 16,17 , 19–21 
ORTC-QLQ-C30 questionnaire 
he European Organisation for Research and Treatment 
f Cancer (EORTC) QLQ-C30 questionnaire is a standard- 
zed and self-administered HRQoL instrument designed for 
se in the estimation of the HRQoL in oncologic patients.
he QLQ-C30 incorporates nine multi-item scales, includ- 
ng ﬁve functional scales, three symptom scales, a global 
ealth and quality of life scale, and six single-item symp- 
om measures. A scale of items is scored from zero to
00; in the functional, the global healthy, and quality-of- 
ife scales, higher scores indicate better health. In the 
ymptom scales, higher score indicates more symptoms. 22 
ingle-symptom items are scaled in the following man- 
er: no symptoms = zero; mild symptoms ≤ 33.33; mod- 
rate symptoms ≤ 66.66; and severe symptoms ≤ 100. 
ulti-item symptoms are scaled in the following manner: 
ero = no symptoms; 0.01–66.65 = mild symptoms; 66.66–
9.99 = moderate symptoms; and 100 = severe symptoms. 
ociodemographic and clinical questionnaire 
nformation was obtained about participants’ age and sex, 
eight, length, comorbidities, medication, smoking habits, 
amily circumstances, and occupational status. 
tatistical analysis 
he characteristics of the study population are presented 
s mean values with standard deviations (SD), as medians 
ith interquartile range (IQR), or as counts with percent- 
ges. Hot-deck imputation was performed for missing data 
hen needed. Statistical comparison between groups was 
erformed by Fisher–Freeman–Halton test, t -test, permuta- 
ion test, or bootstrap-type analysis of variance (ANOVA), 
hen appropriate. Adjusted comparison between groups 
as evaluated using bootstrap-type analysis of covariance 
ANCOVA). Models included sex, age, and Charlson comor- 
idity index as covariates. The bootstrap method was used 
hen the theoretical distribution of the test statistics was 
nknown or in the case of violation of the assumptions (e.g.,
on-normality). Adjusted correlation (partial) coefﬁcients 
ere calculated by the Pearson method. Stata 15.1, Stat- 
Corp LP (College Station, TX, USA) statistical package was 
sed for the analyses. 
thical considerations and reporting 
he study protocol was reviewed and approved by the Ethics 
ommittee of the Hospital District of Helsinki and Uusi- Please cite this article as: J.T.K. Salo, J.P. Repo and R.P. Roine et al
reconstruction of the chest wall, Journal of Plastic, Reconstructive & Aeaa, Helsinki, Finland. A written informed consent was ob-
ained from all patients. Results are reported adhering to
he Strengthening the Reporting of Observational Studies in 
pidemiology (STROBE) statement. 23 
esults 
hest wall resection and reconstruction patients 
 total of 17 men and 38 women (response rate 71%) with
 mean (SD) age of 68 (14) years completed the question-
aires. The median (range, SD) time after primary surgery
as 66 (16–241, 67) months. Table 1 lists the sociodemo-
raphic and clinical characteristics of these patients. 
The respondents had been operated because of soft 
issue sarcoma ( n = 16), advanced breast cancer ( n = 15),
steo- or chondrosarcoma ( n = 14), or another tumor
 n = 10) of the chest wall. Resections of the chest wall were
ull thickness in 29 cases and partial thickness in 26 cases.
ll patients had undergone one-stage surgery including tu- 
or removal and defect reconstruction in the same proce-
ure. In eight patients, the defect could be closed primarily,
hereas the remaining 47 (85%) patients required chest wall
econstruction: soft tissue ﬂap reconstruction in eight cases 
 Figure 1 (a)–(c)), skeletal stabilization with mesh or mesh-
ement-mesh in 15 cases (sandwich method), and skeletal 
tabilization and soft tissue ﬂap reconstruction in 24 cases 
 Figure 2 (a)–(d)). Oncological adjuvant treatment was given
o 23/55 (55%) of the patients. ., Health-related quality of life after oncological resection and 
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Figure 1 (a) Advanced breast cancer. (b) Partial-thickness anterolateral chest wall resection. (c) Chest wall reconstruction with 
free musculocutaneus tensor fascia ﬂap. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 In the majority of patients ( n = 46, 84%), no surgical
complications were observed. Complications occurred in
nine cases and three re-operations were needed. Complica-
tions were classiﬁed with the Clavien–Dindo classiﬁcation:
grade II ( n = 5); grade IIIb ( n = 2), or grade IVa ( n = 2). The
most common complication was pneumonia ( n = 3). During
follow-up, four patients developed recurrence of disease
and four developed metastases. 
Comparison of respondents and nonrespondents 
On comparison of respondents ( n = 55) and nonrespondents
( n = 23), there were statistically signiﬁcant differences in
mean age; the respondents were seven years older on aver-
age. There were no statistically signiﬁcant differences be-
tween the two groups for other characteristics. Please cite this article as: J.T.K. Salo, J.P. Repo and R.P. Roine et al
reconstruction of the chest wall, Journal of Plastic, Reconstructive & AComparison of different reconstruction type 
groups 
Table 2 shows the comparison of subject and operative char-
acteristics in different reconstruction type groups. There
was a statistically signiﬁcant difference in the Charlson co-
morbidity index, diagnosis, and full-thickness resection. 
HRQoL (15D) of patients compared to that of 
control population 
The patients’ mean 15D score (0.878, SD 0.111) was compa-
rable to that of the age- and gender-standardized general., Health-related quality of life after oncological resection and 
esthetic Surgery, https://doi.org/10.1016/j.bjps.2019.05.040 
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Figure 2 (a) Chest wall high grade soft tissue sarcoma. (b) Full-thickness anterior chest wall resection. (c) Chest wall stabilization 
with a sandwich technique (methyl–methacrylate between two meshes). (d) Soft tissue reconstruction with pedicled latissimus dorsi 
musculocutaneous ﬂap. 
p
s
p
m
(
Q
A
(  
i
t
 
r
(
C
d
I
i  
“
(  
C
n
d  
t
C
T  
C  
aopulation (0.891, SD 0.041). The difference was neither 
tatistically signiﬁcant nor clinically important. However, 
atients were statistically signiﬁcantly worse off on the di- 
ensions of “Breathing” ( p = 0.043) and “Usual activities”
 p = 0.027) ( Figure 3 ). 
LQ-C30 scores 
mong all patients, the QLQ-C30 Global health status 
HRQoL) was 72 points (zero to 100, worst to best). Scores
n the QLQ-C30 functional scales ranged from 78 (Physical) 
o 91 (Social) points ( Figure 4 ). 
Scores in the Symptom scales (zero to 100, best to worst)
anged from 2 (Nausea/vomiting) to 23 (Fatigue) points 
 Figure 5 ). Please cite this article as: J.T.K. Salo, J.P. Repo and R.P. Roine et al
reconstruction of the chest wall, Journal of Plastic, Reconstructive & Aeomparing quality of life (15D and QLQ-C30) in 
ifferent reconstruction type groups 
n nonadjusted analyses, the mean 15D scores differed 
n a statistically signiﬁcant manner on the dimensions of
Seeing” ( p = 0.003), “Speech” ( p = 0.014), and “Distress”
 p = 0.024). When analyses were adjusted for sex, age, and
harlson comorbidity index, there were no statistically sig- 
iﬁcant differences. There were no statistically signiﬁcant 
ifferences in the mean EORTC QLQ-C30 symptom scores be-
ween the different reconstruction type groups ( Table 3 ). 
omparing quality of life and mean defect size 
here was a partial correlation with the 15D and the QLQ-
30 and with mean defect size when the analyses were
djusted for age, sex, and Charlson comorbidity index. ., Health-related quality of life after oncological resection and 
sthetic Surgery, https://doi.org/10.1016/j.bjps.2019.05.040 
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15D score
0,5 0,6 0,7 0,8 0,9 1,0
15D-score
Sex
Vitality
Distress
Depression
Discomfort and symptoms
Mental function
Usual activities
Excretion
Speech
Eating
Sleeping
Breathing
Hearing
Vision
p=0.027
p=0.043
Controls
Patients
Figure 3 The mean 15D dimension scores and the total 15D score of patients who underwent chest wall reconstruction ( n = 55) 
compared to those of the age- and gender-standardized general population. 
Scores
50 55 60 65 70 75 80 85 90 95 100
Social functioning
Cognitive functioning
Emotional functioning
Role functioning
Physical functioning
Global health status/QoL
Figure 4 Mean QLQ-C30 function scores in patients who underwent chest wall reconstruction. 
Moderate or severe symptom, %
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80
Financial problems
Diarrhoea
Constipation
Appetite loss
Insomnia
Dyspnoea
Pain
Nausea / vomiting
Fatigue
Figure 5 Prevalence of moderate or severe symptoms in patients who underwent chest wall reconstruction. 
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Table 2 Subject and operative characteristics in different reconstruction type groups. 
Reconstruction type p -value 
Primary 
closure 
Chest wall 
stabilization 
Soft tissue 
ﬂap cover 
Chest wall 
stabilization + ﬂap 
n = 8 n = 15 n = 8 n = 24 
Mean age, years , (SD) 72 (8) 62 (17) 75 (13) 67 (14) 0.15 
Number of females, n 7 10 5 16 0.75 
BMI, mean (SD) 27.8 (3.3) 25.1 (3.2) 27.0 (5.9) 25.6 (3.6) 0.37 
Charlson comorbidity index, mean (SD) 2.1 (0.4) 3.1 (1.8) 3.9 (2.2) 3.8 (2.0) < 0.001 
Diagnosis, n 0.002 
Advanced breast cancer 0 3 0 12 
Soft tissue sarcoma 5 3 5 3 
Chondro or bone sarcoma 2 5 0 7 
Others 1 4 3 2 
Chest wall full-thickness resection, n 0 3 2 24 < 0.001 
Mean defect size, cm 2 , (SD) 162 (63) 130 (127) 209 (116) 201 (128) 0.26 
Adjuvant therapy, n 3 5 2 13 0.44 
Recurrence during follow-up, n 0 2 0 2 0.71 
Metastases during follow-up, n 0 1 0 3 0.81 
Median time after primary surgery, 
months, median (range) 
92 
(16–241) 
59 (18–229) 59 (33–207) 73 (29–240) 0.44 
Table 3 The mean 15D scores and the mean EORTC QLQ-30 function scores of patients who underwent chest wall reconstruction 
according to reconstruction type group. 
Reconstruction type p -value 
Primary 
closure 
Chest wall 
stabilization 
Soft tissue 
ﬂap cover 
Chest wall stabi- 
lization + ﬂap 
Crude Adjusted a 
n = 8 n = 15 n = 8 n = 24 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
EORTC QLQ-C30: 
Global health status/QoL 79 (17) 69 (22) 64 (27) 76 (17) 0.38 0.53 
Functional scales 
Physical 79 (27) 74 (31) 63 (31) 86 (14) 0.14 0.17 
Role 83 (24) 79 (29) 65 (46) 90 (15) 0.24 0.35 
Emotional 94 (10) 84 (18) 74 (25) 91 (11) 0.095 0.29 
Cognitive 92 (18) 86 (22) 81 (24) 94 (10) 0.25 0.58 
Social 98 (6) 90 (16) 75 (33) 95 (13) 0.11 0.55 
15D: 
Total score 0.881 (0.069) 0.862 (0.116) 0.798 (0.199) 0.910 (0.060) 0.18 0.28 
Move 0.907 (0.264) 0.943 (0.119) 0.871 (0.269) 0.921 (0.179) 0.89 0.93 
See 1.000 (0.000) 0.957 (0.089) 0.792 (0.211) 1.000 (0.000) 0.003 0.51 
Hear 0.937 (0.116) 0.810 (0.301) 0.778 (0.346) 0.832 (0.221) 0.20 0.25 
Breath 0.701 (0.307) 0.769 (0.185) 0.766 (0.285) 0.836 (0.154) 0.44 0.45 
Sleep 1.000 (0.000) 0.984 (0.062) 1.000 (0.000) 1.000 (0.000) 0.23 0.26 
Eat 1.000 (0.000) 0.923 (0.220) 0.912 (0.164) 1.000 (0.000) 0.12 0.16 
Speech 0.815 (0.154) 0.960 (0.104) 0.724 (0.278) 0.938 (0.123) 0.014 0.34 
Excretion 0.921 (0.146) 0.777 (0.307) 0.770 (0.269) 0.897 (0.195) 0.28 0.19 
Usual activities 0.822 (0.215) 0.792 (0.315) 0.686(0.308) 0.848 (0.167) 0.52 0.46 
Mental function 0.911 (0.165) 0.929 (0.148) 0.822 (0.191) 0.926 (0.148) 0.53 0.64 
Discomfort and symptoms 0.776 (0.213) 0.761 (0.168) 0.689 (0.365) 0.788 (0.187) 0.88 0.17 
Depression 0.883 (0.126) 0.858 (0.151) 0.794 (0.264) 0.951 (0.097) 0.053 0.43 
Distress 0.931 (0.127) 0.874 (0.171) 0.767 (0.219) 0.966 (0.093) 0.024 0.84 
Vitality 0.854 (0.178) 0.796 (0.179) 0.735 (0.320) 0.874 (0.156) 0.40 0.45 
Sex 0.819 (0.307) 0.758 (0.346) 0.858 (0.213) 0.891 (0.144) 0.49 0.40 
a Adjusted for sex, age, and Charlson comorbidity index. 
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 The extent of the defect correlated only marginally with
the generic HRQoL ( r = −0.28;95% CI: −0.51 to −0.01;
p = 0.047, adjusted for age, gender, and Charlson comorbid-
ity index), but QLQ-C30 correlated strongly with the extent
of the defect ( r = −0.37;95% CI: −0.58 to −0.12; p = 0.007
adjusted for age, gender, and Charlson comorbidity index). 
Discussion 
The main ﬁnding of the present study is that long-term
HRQoL in patients after chest wall reconstruction following
oncological resection is largely comparable to that of the
age- and gender-standardized general population. Patients
were statistically signiﬁcantly worse off on the dimensions
of “Breathing” and “Usual activities.” In different recon-
struction type groups, there were no statistically signiﬁcant
differences in HRQoL after analyses were adjusted for sex,
age, and Charlson comorbidity index. 
There has been limited data on quality of life after chest
wall resection and reconstruction compared to those of the
healthy control population. In line with our ﬁndings, Liu
et al. 10 reported that chest wall resection with pulmonary
resection does not worsen HRQoL compared to pulmonary
resection without chest wall resection. Their sample size
( n = 63) was large, but they did not compare results to a
sample of age- and gender-standardized general popula-
tion, and they did not report the reconstruction methods,
which can be considered a limitation when reporting the
outcomes. 
Daigeler et al. 9 reported that after chest wall reconstruc-
tion, quality of life was signiﬁcantly reduced compared to
that in the healthy control group. Their sample size was 36
patients, and they did not analyze the diagnosis of patients,
size of the resection, or the reconstruction method in this
study group. 
Heuker et al. 8 noticed that subjective assessment of dys-
pnea was correlated well with patient-perceived HRQoL.
Results of our study also indicate that limitation in breath-
ing can occur and HRQoL can be decreased. Heuker et al.
did not report in their study ( n = 23) whether patients had
undergone oncological adjuvant treatment, which can have
an impact on HRQoL. Tacconi et al. 12 discovered that the ex-
tent of chest wall resection, preoperative forced expiratory
volume, and postoperative decline in forced vital capacity
were the main indicators for decline in HRQoL as measured
by the SF-36. Decline of HRQoL was correlated with the ex-
tent of surgical trauma. Likewise, we also noticed in our
data the correlation between QLQ-C30 and mean defect size
and had similar ﬁndings that some limitations in breathing
can occur. 
A meta-analysis of HRQOL results in patients who under-
went chest wall resection treated for recurrent breast can-
cer was not feasible due to the above-mentioned reporting
inconsistencies. 13 Validated quantitative metrics were used
in only one study to report HRQoL. In that study, the authors
used The Union for International Cancer Control’s (UICC)
performance status, but there were only six patients. In that
study, the HRQoL improved due to the treatment. 11 Further-
more, in a study by Toija et al., after treatment of breast
cancer (without chest wall resection and reconstruction),
the mean 15D HRQoL score was 0.886. 24 Rautalin et al.Please cite this article as: J.T.K. Salo, J.P. Repo and R.P. Roine et al
reconstruction of the chest wall, Journal of Plastic, Reconstructive & Afound that the mean 15D HRQoL score after treatment of
breast cancer is 0.91. 25 The present study found relatively
similar results of mean 15D score of 0.88 among patients
who underwent chest wall resection and reconstruction due
to malignancy. 
The follow-up was long in our study. Median time after
primary surgery was 66 months, and the number of respon-
dents in this study was acceptable to draw a conclusion. The
sample size is comparable favorably with that of previous
studies. 9–13 The response rate (71%) can also be considered
acceptable. In our study, we report the extent of surgical
operation, need for reconstruction, method of reconstruc-
tion, and patient’s diagnosis. We have compared our results
to those of a large control population. 
We acknowledge that there are also some limitations in
our study. The most signiﬁcant limitation is that the study
design was not prospective. The heterogeneity of the pa-
tients, heterogeneity of the treatments (surgical and onco-
logical), and variability of timing of surgery to completion
of questionnaire are also signiﬁcant limitations in our study,
and these could be confounding features. The lack of preop-
erative assessment negates our ability to assess the real im-
pact of treatment on HRQoL. Comparing results in relatively
small reconstruction type subgroups to those of general con-
trol population is not reasonable. Possible differences in the
subgroups of full- and partial-thickness resections could not
be reliably assessed owing to the small sample size. Some of
the patients were treated with oncological adjuvant treat-
ment; however, the possible effect could not be analyzed
owing to the small sample size. As the study population was
heterogeneous, the results could be generalized in patients
having undergone chest wall resection and reconstruction
for various pathologies. Moreover, comparison of the QLQ-
C30 scores with those of general population could poten-
tially have provided even deeper insight into the impact of
chest wall tumor resection and reconstruction to HRQoL.
However, this study limited the comparison to the generic
HRQoL assessed using the 15D instrument. By the start of
the HRQoL data collection in February 2016, 55 (41%) of the
135 surgical patients who had been operated between 1997
and 2015 had died. These patients could have had most ad-
vanced disease, and this fact could have affected the results
reported in the present study. 
Conclusions 
In conclusion, the main ﬁnding of this study is that the long-
term HRQoL in patients after chest wall reconstruction fol-
lowing oncological resection is fair and comparable to that
of the age- and gender-standardized general population.
Limitations in breathing and usual activities can occur. Fur-
ther prospective studies are needed to assess the true im-
pact of oncological resection and reconstructive surgery in
these rare patients. 
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